Cargando…
PKCβII inhibition attenuates myocardial infarction induced heart failure and is associated with a reduction of fibrosis and pro-inflammatory responses
Protein kinase C βII (PKCβII) levels increase in the myocardium of patients with end-stage heart failure (HF). Also targeted overexpression of PKCβII in the myocardium of mice leads to dilated cardiomyopathy associated with inflammation, fibrosis and myocardial dysfunction. These reports suggest a d...
Autores principales: | Palaniyandi, Suresh Selvaraj, Ferreira, Julio Cesar Batista, Brum, Patricia Chakur, Mochly-Rosen, Daria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136735/ https://www.ncbi.nlm.nih.gov/pubmed/20874717 http://dx.doi.org/10.1111/j.1582-4934.2010.01174.x |
Ejemplares similares
-
Protein Quality Control Disruption by PKCβII in Heart Failure; Rescue by the Selective PKCβII Inhibitor, βIIV5-3
por: Ferreira, Julio C. B., et al.
Publicado: (2012) -
Protein kinase C in heart failure: a therapeutic target?
por: Palaniyandi, Suresh Selvaraj, et al.
Publicado: (2009) -
Ischaemic preconditioning improves proteasomal activity and increases the degradation of δPKC during reperfusion
por: Churchill, Eric N., et al.
Publicado: (2010) -
Aldehyde dehydrogenase 2 activation and coevolution of its εPKC-mediated phosphorylation sites
por: Nene, Aishwarya, et al.
Publicado: (2017) -
Sustained inhibition of PKCα reduces intravasation and lung seeding during mammary tumor metastasis in an in vivo mouse model
por: Kim, Jeewon, et al.
Publicado: (2010)